8-K
filed June 2, 2026, 5:30 PM ET
ticker NRXP
CIK 0001719406
other material
confidence high
sentiment neutral
materiality 0.50
NRx Pharmaceuticals proposes public offering of common stock; terms not set
NRX Pharmaceuticals, Inc.
- Intends to offer common stock in underwritten public offering; no size or price disclosed.
- Underwriter granted 30-day option to purchase up to 15% additional shares on same terms.
- BTIG is lead bookrunner; Lucid Capital Markets joint bookrunner for the offering.
- Net proceeds to be used for working capital and general corporate purposes.
- Offering under effective shelf registration statement (File No. 333-288205) declared effective Dec 22, 2025.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-26-019196
- form_type
- 8-K
- ticker
- NRXP
- cik
- 0001719406
- company_name
- NRX Pharmaceuticals, Inc.
- filed_at
- 2026-06-02T21:30:08+00:00
- discovered_at
- 2026-06-02T21:32:00.311730+00:00
- generated_at
- 2026-06-02T21:32:08.349927+00:00
- sec_items
- ["8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-26-019196
- json_url
- https://secwatch.observer/filing/0001437749-26-019196.json
- markdown_url
- https://secwatch.observer/filing/0001437749-26-019196.md
- text_url
- https://secwatch.observer/filing/0001437749-26-019196.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/0001437749-26-019196-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/nrxp20260602_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
AVA
Avista signs non-binding MOU for 125 MW load, expandable to 500 MW by 2032
AVISTA CORP
June 2, 2026, 5:02 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
ARVN
Arvinas to out-license ARV-806 after completing Phase 1 dose escalation
ARVINAS, INC.
June 2, 2026, 4:39 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
JAGX
Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8
Jaguar Health, Inc.
June 2, 2026, 4:10 PM ET
other_material
Items 1.01, 3.02, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
OTAI
Starlink AI Acquisition closes partial over-allotment, adds $5M to trust
Starlink AI Acquisition Corp
June 2, 2026, 4:05 PM ET
other_material
Items 3.02, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MLI
Mueller Industries announces 2-for-1 stock split; record date June 25, 2026
MUELLER INDUSTRIES INC
June 2, 2026, 10:47 AM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
SLS
SELLAS Life Sciences raised $28.7M from warrant exercises in Apr-May 2026
SELLAS Life Sciences Group, Inc.
June 2, 2026, 8:30 AM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MBOT
Microbot Medical secures first North Carolina customer for LIBERTY robotic system
Microbot Medical Inc.
June 2, 2026, 8:30 AM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
NOG
NOG files resale prospectus for 3.7M shares issued in Parallax Acquisition
NORTHERN OIL & GAS, INC.
June 2, 2026, 8:21 AM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.